These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8688103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP, Chen H, Du BJ, Liu YL, Wang YH, Zhang JP.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group.
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [Abstract] [Full Text] [Related]

  • 4. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group.
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [Abstract] [Full Text] [Related]

  • 5. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON, Dorn C, van de Vondel P, Ulrich U, Schmolling J.
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [Abstract] [Full Text] [Related]

  • 6. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, Perry KG, Varner M, Goodwin TM, Lane R, Smith J, Shangold G, Creasy GW.
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [Abstract] [Full Text] [Related]

  • 7. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
    Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, Hobbins J, Rayburn W, Shangold G, Wang J, Smith J, Creasy GW.
    Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
    [Abstract] [Full Text] [Related]

  • 8. Atosiban versus usual care for the management of preterm labor.
    Husslein P, Cabero Roura L, Dudenhausen JW, Helmer H, Frydman R, Rizzo N, Schneider D.
    J Perinat Med; 2007 May; 35(4):305-13. PubMed ID: 17614750
    [Abstract] [Full Text] [Related]

  • 9. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
    Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, Hayashi R, Valenzuela G, Creasy GW, Merriman R.
    Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
    [Abstract] [Full Text] [Related]

  • 10. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
    Goodwin TM, Valenzuela GJ, Silver H, Creasy G.
    Obstet Gynecol; 1996 Sep; 88(3):331-6. PubMed ID: 8752234
    [Abstract] [Full Text] [Related]

  • 11. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM.
    BMC Pregnancy Childbirth; 2007 Jun 01; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [Abstract] [Full Text] [Related]

  • 12. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF.
    BJOG; 2003 Apr 01; 110 Suppl 20():108-12. PubMed ID: 12763125
    [Abstract] [Full Text] [Related]

  • 13. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P, Roura LC, Dudenhausen J, Helmer H, Frydman R, Rizzo N, Schneider D, TREASURE study group.
    BJOG; 2006 Dec 01; 113 Suppl 3():105-10. PubMed ID: 17206976
    [Abstract] [Full Text] [Related]

  • 14. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
    Grignaffini A, Soncini E, Ronzoni E, Lo Cane F, Anfuso S, Nardelli GB.
    Minerva Ginecol; 2007 Oct 01; 59(5):481-9. PubMed ID: 17912174
    [Abstract] [Full Text] [Related]

  • 15. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A, Hopp H, Dudenhausen J.
    Z Geburtshilfe Neonatol; 2009 Oct 01; 213(5):201-6. PubMed ID: 19856243
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist.
    Grigsby PL, Poore KR, Hirst JJ, Jenkin G.
    Am J Obstet Gynecol; 2000 Sep 01; 183(3):649-57. PubMed ID: 10992188
    [Abstract] [Full Text] [Related]

  • 17. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY, Park YW, Yoon BH, Cho YK, Yang JH, Lee Y, Kim A.
    BJOG; 2006 Nov 01; 113(11):1228-34. PubMed ID: 16978233
    [Abstract] [Full Text] [Related]

  • 18. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group.
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct 01; 98(2):177-85. PubMed ID: 11574128
    [Abstract] [Full Text] [Related]

  • 19. Atosiban.
    Shubert PJ.
    Clin Obstet Gynecol; 1995 Dec 01; 38(4):722-4. PubMed ID: 8616970
    [Abstract] [Full Text] [Related]

  • 20. [Tocolysis. Atosiban, an ocytcin-receptor antagonist].
    Schmitz T, Cabrol D.
    J Gynecol Obstet Biol Reprod (Paris); 2001 May 01; 30(3):238-45. PubMed ID: 11397999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.